Clinical Trials Directory

Trials / Completed

CompletedNCT01213524

Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia

Biological and Behavioral Mechanisms of Smoking in Schizophrenia

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Brown University · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to investigate the relative contributions of nicotine replacement and sensorimotor replacement (i.e., smoking denicotinized cigarettes) on abstinence-induced smoking urges, withdrawal-related negative affect, psychiatric symptoms, cognitive task performance and 90-min ad libitum usual-brand smoking behavior in smokers with schizophrenia and non-psychiatric smokers.

Detailed description

This study used a mixed between- and within-subjects design to investigate the separate and combined effects of sensorimotor replacement for smoking (very low nicotine content \[VLNC\] cigarettes vs. no cigarettes) and transdermal nicotine replacement (42 mg nicotine \[NIC\] vs. placebo \[PLA\] patches) in smokers with schizophrenia and control smokers without psychiatric illness. Each session contained a 5-h controlled administration period in which participants underwent the following conditions, in counterbalanced order: VLNC + NIC, VLNC + PLA, no cigarettes + NIC, no cigarettes + PLA, Usual Brand cigarettes + no patches. Next, participants completed measures of cigarette craving, nicotine withdrawal, smoking habit withdrawal, cigarette subjective effects, psychiatric symptoms and cognitive task performance followed by a 90-min period of ad libitum usual-brand smoking.

Conditions

Interventions

TypeNameDescription
BEHAVIORALsensorimotor replacementdenicotinized cigarettes
DRUG42 mg transdermal nicotine replacement2 21-mg nicotine patches
DRUGPlacebo transdermal nicotine2 placebo patches matched to 21-mg nicotine patches
OTHERusual brand smokingparticipant smokes usual brand of cigarette

Timeline

Start date
2005-09-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2010-10-04
Last updated
2020-10-19
Results posted
2020-09-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01213524. Inclusion in this directory is not an endorsement.